Caribou Biosciences (CRBU) Shares Outstanding (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Shares Outstanding data on file, last reported at $97.0 million in Q1 2026.

• Quarterly Shares Outstanding rose 4.24% year-over-year to $97.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.0 million (up 4.24% YoY) and the FY2025 annual result came in at $95.1 million, up 2.99% from the prior year.
• Shares Outstanding advanced to $97.0 million in Q1 2026 per CRBU's latest filing, from $95.1 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $97.0 million in Q1 2026 and bottomed at $60.7 million in Q1 2022.
• The 5-year median for Shares Outstanding is $90.3 million (2024), against an average of $81.4 million.
• The widest annual swing landed in 2022, when Shares Outstanding soared 489.48%; it then rose 1.04% in 2023.
• Tracing CRBU's Shares Outstanding over 5 years: stood at $61.0 million in 2022, then surged by 44.93% to $88.4 million in 2023, then increased by 4.44% to $92.4 million in 2024, then rose by 2.99% to $95.1 million in 2025, then advanced by 1.9% to $97.0 million in 2026.
• Per Business Quant, the three latest CRBU Shares Outstanding figures stand at $97.0 million (Q1 2026), $95.1 million (Q4 2025), and $93.5 million (Q3 2025).

Peer Comparison